Bill Hicks will speak on a panel entitled, "The American JOBS Act: What Does it Really Mean for the Biotech Industry?" at the NYBA 21st Annual Meeting at the Marriott Marquis Hotel in New York City.
The American JOBS (Jumpstart Our Business Startups) Act, signed by President Obama on April 5, 2012, is a $450 billion legislative package designed to "jumpstart the economy" and restore opportunities for America's primary job creators: small businesses, startups and entrepreneurs. The legislation lifts SEC restrictions on running advertisements soliciting new investors and permits "crowdfunding" so that entrepreneurs can raise equity capital from larger pools of small investors. Small private companies can sell up to $50 million in shares as part of a public offering before having to register with the SEC, and could have as many as 1,000 shareholders, upf from the current cap of 500. Biotech companies, of course, are notoriously susceptible to "valley of death" when it comes to financing.
Bill Hicks, Member, Mintz Levin
Richard Catalano, Partner, KPMG LLP
The American JOBS Act: What Does it Really Mean for the Biotech Industry?